RNA therapy: Are we using the right molecules?Ai‐Ming Yu, Mei‐Juan Tu, Chao Jian et al.|Pharmacology & Therapeutics|2018Cited by 172
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growthYong Zhao, Ai‐Ming Yu, Mei‐Juan Tu et al.|Biochemical Pharmacology|2015Cited by 64
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse modelsMei‐Juan Tu, Ai‐Ming Yu, Pui Yan Ho et al.|Cancer Letters|2018Cited by 50
A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesisYixin Chen, Huichang Bi, Yanying Zhou et al.|Theranostics|2020Cited by 49
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrestYong Zhao, Ai‐Ming Yu, Mei‐Juan Tu et al.|Scientific Reports|2016Cited by 43